195 related articles for article (PubMed ID: 33161794)
21. Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis.
Shimizu H; Saitoh T; Machida S; Kako S; Doki N; Mori T; Sakura T; Kanda Y; Kanamori H; Miyawaki S; Okamoto S;
Eur J Haematol; 2015 Nov; 95(5):455-60. PubMed ID: 25605541
[TBL] [Abstract][Full Text] [Related]
22. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
[TBL] [Abstract][Full Text] [Related]
23. [A study of mixed phenotype acute leukemia based on the 2008 World Health Organization classification].
Park J; Chae H; Kim M; Lim J; Kim Y; Lee J; Chung NG; Cho B; Kim HK; Lee S; Han K
Korean J Lab Med; 2010 Dec; 30(6):525-32. PubMed ID: 21157134
[TBL] [Abstract][Full Text] [Related]
24. Zinc finger protein 384 (
Sudutan T; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Kucukcankurt F; Celkan T; Timur C; Ozdemir GN; Hacısalihoglu S; Gelen SA; Sayitoğlu M
Leuk Lymphoma; 2022 Dec; 63(12):2931-2939. PubMed ID: 35921545
[TBL] [Abstract][Full Text] [Related]
25. Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation.
Liu S; Cui Q; Dai H; Song B; Cui W; Xue S; Qiu H; Miao M; Jin Z; Li C; Fu C; Wang Y; Sun A; Chen S; Zhu X; Wu D; Tang X
Transplant Cell Ther; 2021 Jun; 27(6):481.e1-481.e7. PubMed ID: 33785365
[TBL] [Abstract][Full Text] [Related]
26. Lymphoid blasts with aberrant myeloid marker expression and BCR/ABL1: Is it mixed phenotype acute leukemia or B lymphoblastic leukemia?
Shopsowitz KE; Shah K; Tsui H
Cytometry B Clin Cytom; 2022 Jan; 102(1):73-75. PubMed ID: 33780164
[No Abstract] [Full Text] [Related]
27. Acute leukemias of ambiguous origin.
Porwit A; Béné MC
Am J Clin Pathol; 2015 Sep; 144(3):361-76. PubMed ID: 26276768
[TBL] [Abstract][Full Text] [Related]
28. First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants.
Shiozawa Y; Fujita S; Nannya Y; Ogawa S; Nomura N; Kiguchi T; Sezaki N; Kudo H; Toyama T
Int J Hematol; 2024 Apr; 119(4):465-471. PubMed ID: 38424413
[TBL] [Abstract][Full Text] [Related]
29. Optimal therapeutic strategies for mixed phenotype acute leukemia.
Wolach O; Stone RM
Curr Opin Hematol; 2020 Mar; 27(2):95-102. PubMed ID: 31913151
[TBL] [Abstract][Full Text] [Related]
30. [Study on the clinical characteristics of 32 patients with mixed phenotype acute leukemia].
Zhang YM; Wu DP; Sun AN; Qiu HY; Sun YM; He GS; Jin ZM; Tang XW; Miao M; Fu ZZ; Han Y; Chen SN; Zhu MQ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):12-6. PubMed ID: 21429394
[TBL] [Abstract][Full Text] [Related]
31. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
Orgel E; Alexander TB; Wood BL; Kahwash SB; Devidas M; Dai Y; Alonzo TA; Mullighan CG; Inaba H; Hunger SP; Raetz EA; Gamis AS; Rabin KR; Carroll AJ; Heerema NA; Berman JN; Woods WG; Loh ML; Zweidler-McKay PA; Horan JT;
Cancer; 2020 Feb; 126(3):593-601. PubMed ID: 31661160
[TBL] [Abstract][Full Text] [Related]
32. Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic Strategies.
George BS; Yohannan B; Gonzalez A; Rios A
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009521
[TBL] [Abstract][Full Text] [Related]
33. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
[TBL] [Abstract][Full Text] [Related]
34. Mixed phenotype acute leukemia in a child associated with a NUP98-NSD1 fusion and NRAS p.Gly61Arg mutation.
Ganapathi SS; Raikar SS; Yatsenko SA; Djokic M; Bukowinski A
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1372. PubMed ID: 33784031
[TBL] [Abstract][Full Text] [Related]
35. Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls.
Charles NJ; Boyer DF
Arch Pathol Lab Med; 2017 Nov; 141(11):1462-1468. PubMed ID: 29072953
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric Flow Cytometry in Mixed Phenotype Acute Leukemia.
Koulmane Laxminarayana SL; Madireddy N; Manohar C; Udupa K
Indian J Hematol Blood Transfus; 2019 Jul; 35(3):451-458. PubMed ID: 31388256
[TBL] [Abstract][Full Text] [Related]
37. Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia.
Pallavajjala A; Kim D; Li T; Ghiaur G; Jones RJ; Burns KH; Salzberg SL; Ning Y
Leuk Lymphoma; 2018 May; 59(5):1231-1238. PubMed ID: 28882084
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia.
Munker R; Brazauskas R; Wang HL; de Lima M; Khoury HJ; Gale RP; Maziarz RT; Sandmaier BM; Weisdorf D; Saber W;
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1024-1029. PubMed ID: 26903380
[TBL] [Abstract][Full Text] [Related]
39. Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy.
Wolach O; Stone RM
Curr Opin Hematol; 2017 Mar; 24(2):139-145. PubMed ID: 28099272
[TBL] [Abstract][Full Text] [Related]
40. How I treat mixed-phenotype acute leukemia.
Wolach O; Stone RM
Blood; 2015 Apr; 125(16):2477-85. PubMed ID: 25605373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
